MicroRNA-1 Suppresses Tumor Progression and UHRF1 Expression in Cholangiocarcinoma
Authors:
- Makoto MutoMMMakoto Muto
- Teruhide IshigameTITeruhide Ishigame
- Takashi KimuraTKTakashi Kimura
- Naoya SatoNSNaoya Sato
- Yasuhide KofunatoYKYasuhide Kofunato
- Akira KenjoAKAkira Kenjo
- Hiroyuki YamamotoHYHiroyuki Yamamoto
- Yuhki YokoyamaYYYuhki Yokoyama
- Hirofumi YamamotoHYHirofumi Yamamoto
- Shigeru MarubashiSMShigeru Marubashi
Open Access
- 3 December 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11718
Abstract
MicroRNAs (miRNAs) have been shown to suppress tumor progression in several cancers, including cholangiocarcinoma; however, their mechanisms and roles remain largely unexplored. In this study, we aimed to identify novel miRNAs and molecules associated with cholangiocarcinoma progression. Using miRNA and mRNA microarrays from surgically resected specimens, we identified microRNA-1 (miR-1) as significantly downregulated in cholangiocarcinoma tissues and selected it for further analysis. In the in vitro assay, miR-1 was transfected into cholangiocarcinoma cell lines to assess its effect on tumor progression. Proliferation and migration/invasion assays demonstrated significant tumor suppression in miR-1-transfected cells. Additionally, cell cycle and apoptosis assays revealed an increase in cells in the G1 and G2/M phases, a decrease in the S phase, and an elevation in apoptosis rates in miR-1-transfected cells. Further analysis of the miRNA and mRNA microarray data identified ubiquitin-like with plant homeodomain and ring finger domains 1 (UHRF1) as a molecule potentially associated with miR-1. Quantitative RT-PCR and Western blotting analysis confirmed that UHRF1 expression was suppressed following miR-1 transfection. This study demonstrated that cholangiocarcinoma progression was suppressed by restoring miR-1 expression, suggesting that UHRF1 expression is involved in cholangiocarcinoma progression. The results of this study provide new insights into the molecular mechanisms underlying cholangiocarcinoma progression.Keywords
Funding Information
- JSPS KAKENHI (JP17K16574)
This publication has 47 references indexed in Scilit:
- Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agentMolecular Therapy Nucleic Acids, 2024
- CholangiocarcinomaNature Reviews Disease Primers, 2021
- MicroRNA: A signature for cancer progressionBiomedicine & Pharmacotherapy, 2021
- miR‐373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1The Kaohsiung Journal of Medical Sciences, 2020
- UHRF1 is regulated by miR‐124‐3p and promotes cell proliferation in intrahepatic cholangiocarcinomaJournal of Cellular Physiology, 2019
- Survival after Resection of Multiple Tumor Foci of Intrahepatic CholangiocarcinomaJournal of Gastrointestinal Surgery, 2019
- NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patientsCell Death & Disease, 2019
- Surgical resection for Bismuth type IV perihilar cholangiocarcinomaBritish Journal of Surgery, 2017
- MicroRNA‐1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor‐5 (API‐5)FEBS Letters, 2014
- Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinomaLaboratory Investigation, 2005